Skip to content

Nutritional Education and the Prevention of Iron Depletion in Children 9 Months to 2 Years

Nutritional Education and the Prevention of Iron Depletion in Children 9 Months to 2 Years: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00907088
Enrollment
251
Registered
2009-05-22
Start date
2006-01-31
Completion date
2009-05-31
Last updated
2014-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency

Keywords

Iron depletion, Children, Educational intervention, Office-based

Brief summary

Iron depletion in young children is common and may progress to iron deficiency anemia which is associated with irreversible neurodevelopmental effects. Efforts to prevent iron depletion are key to preventing these effects. In a recent study of 150 young children (12 to 38 months), we found that bottle fed children were almost three times as likely to be iron depleted compared with cup fed children (37% vs 18%). Thus, we hypothesize that an educational intervention designed to encourage timely bottle weaning will lead to a reduction in iron depletion.

Detailed description

We plan to undertake a randomized controlled trial to evaluate the effectiveness of an office-based educational intervention for the prevention of iron depletion in young children. Healthy children will be recruited from a community pediatric office which serves a diverse, urban population. Children will be randomized to the intervention education group or the control education group at 9 months of age. Blood work (\ 4mL) for complete blood count and ferritin along with additional measures such as transferrin, iron, and reticulocyte count will be obtained at 24 months of age. Rates of iron depletion and anemia will be compared in the two groups. The two groups will also have 25-hydroxy vitamin D, calcium and alkaline phosphatase levels analyzed at the 24 month visit to ensure that the intervention for prevention of iron depletion does not adversely affect these measures.

Interventions

OTHERHealthy milk intake

In addition to the standard nutrition counselling, the intervention group will receive specific information regarding healthy milk intake (2 cups per day, maximum 16 ounces) and the potential negative health effects of prolonged bottle use and excessive milk intake including anemia, iron depletion, and dental carries.

Parents of children will receive nutrition counselling via trained study personnel, including recommendations for iron containing food choices and timing of cow's milk introduction. This group will also receive a colourful nutrition book.

Sponsors

The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
9 Months to 9 Months
Healthy volunteers
Yes

Inclusion criteria

* Children aged 9 months who are attending a routine primary care well-child visit. * Children who are in good general health. * Children whose parents provide informed consent to participate.

Exclusion criteria

* Children with chronic illness. * Children with birth weight less than 2.5 kg. * Children with previously diagnosed anemia (including known iron deficiency anemia). This includes children with marrow failure (aplastic anemia, Fanconi anemia), hemoglobinopathies (sickle cell disease, thalassemia), lead intoxication, sideroblastic anemia, megaloblastic anemia, enzymopathies (G6PD deficiency, pyruvate kinase deficiency), or membranopathies (hereditary spherocytosis). * Children currently receiving medications associated with anemia. This includes children taking antimetabolites or phenytoin. * Children currently receiving iron supplementation other than iron fortified formula.

Design outcomes

Primary

MeasureTime frame
The Primary Outcome is Iron Depletion, and Will be Defined as Serum Ferritin <10 mcg/L.Age 24 months

Secondary

MeasureTime frame
Iron Deficiency (Defined as Serum Ferritin <10 mcg/L and MCV < 70 mcm3 Iron Deficiency.Age 24 months
IDA (Hemoglobin < 110 g/L With Iron Deficiency)Age 24 months

Countries

Canada

Participant flow

Participants by arm

ArmCount
Control Group
Standard nutrition counselling: Parents of children will receive nutrition counselling via trained study personnel based on the Canadian Paediatric Society Guidelines. Nutrition counselling occurs at the 9-month visit and is repeated at the 15-month visit if the child has not transitioned into the use of a cup. Recommendations include iron containing food choices and timing of cow's milk introduction. This group will also receive a colourful nutrition book.
122
Intervention Group
Healthy milk intake: In addition to the standard nutrition counselling provided in the control group, the intervention group will receive specific information regarding healthy milk intake (2 cups per day, maximum 16 ounces) and the potential negative health effects of prolonged bottle use and excessive milk intake including anemia, iron depletion, and dental carries.
129
Total251

Baseline characteristics

CharacteristicTotalControl GroupIntervention Group
Age, Categorical
<=18 years
251 Participants122 Participants129 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Bottle use
Bottle Only
121 participants60 participants61 participants
Bottle use
Breast and Bottle
41 participants15 participants26 participants
Bottle use
Breast Only
84 participants46 participants38 participants
Bottle use
Information Not Available
5 participants1 participants4 participants
Plan to bottle-wean by 2 years old
No Information Available
121 participants55 participants66 participants
Plan to bottle-wean by 2 years old
Plan to Bottle Wean By 2 Years Old
130 participants67 participants63 participants
Race/Ethnicity, Customized
Asian
30 participants18 participants12 participants
Race/Ethnicity, Customized
Black
13 participants6 participants7 participants
Race/Ethnicity, Customized
Hispanic
31 participants13 participants18 participants
Race/Ethnicity, Customized
White
177 participants85 participants92 participants
Sex: Female, Male
Female
119 Participants53 Participants66 Participants
Sex: Female, Male
Male
132 Participants69 Participants63 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1220 / 129
serious
Total, serious adverse events
0 / 1220 / 129

Outcome results

Primary

The Primary Outcome is Iron Depletion, and Will be Defined as Serum Ferritin <10 mcg/L.

Time frame: Age 24 months

ArmMeasureGroupValue (NUMBER)
Control GroupThe Primary Outcome is Iron Depletion, and Will be Defined as Serum Ferritin <10 mcg/L.No Iron Depletion64 participants
Control GroupThe Primary Outcome is Iron Depletion, and Will be Defined as Serum Ferritin <10 mcg/L.Yes Iron Depletion13 participants
Control GroupThe Primary Outcome is Iron Depletion, and Will be Defined as Serum Ferritin <10 mcg/L.Unknown22 participants
Intervention GroupThe Primary Outcome is Iron Depletion, and Will be Defined as Serum Ferritin <10 mcg/L.Yes Iron Depletion10 participants
Intervention GroupThe Primary Outcome is Iron Depletion, and Will be Defined as Serum Ferritin <10 mcg/L.No Iron Depletion71 participants
Intervention GroupThe Primary Outcome is Iron Depletion, and Will be Defined as Serum Ferritin <10 mcg/L.Unknown21 participants
p-value: 0.42Chi-squared
Secondary

IDA (Hemoglobin < 110 g/L With Iron Deficiency)

Time frame: Age 24 months

Secondary

Iron Deficiency (Defined as Serum Ferritin <10 mcg/L and MCV < 70 mcm3 Iron Deficiency.

Time frame: Age 24 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026